A compounded peptide that moves from Category 2 to Category 1 is not an FDA-approved drug
Both eventually reach similar endpoints
In both cases, the administration schedule is 1,000 micrograms/day for 1 week at the beginning of treatment, 1,000 micrograms/week for the next 4-8 weeks, and 1,000 micrograms/month as a maintenance dose
(The agency has not announced that it intends to do so.) "Ultimately, what we would hope is, before the end of the year, patients would be able to go to their doctor, work through maybe a telehealth provider, and then be able to get a prescription for this under monitored medical supervision," he said
Rotate injection sites within this general area to prevent localized irritation or scar tissue formation
(2024) Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Able, C